Endoscopic management of familial adenomatous polyposis in patients refusing colectomy

Background and study aims: Colectomy protects against colorectal cancer in familial adenomatous polyposis (FAP); however, some patients with FAP refuse surgery. The aim of this study was to evaluate the feasibility and safety of endoscopic management of these patients.

Patients and methods: A retrospective review of medical records was performed to identify adult patients with FAP who refused colectomy and were managed by repeated colonoscopies to remove numerous polyps between 2001 and 2012. Polyps were removed by hot snare polypectomy or endoscopic mucosal resection. Polyps of < 10 mm in size and without endoscopic features suggesting cancer were discarded without histological examination; the remaining polyps were examined histologically.

Results: Of the 95 eligible patients, five (5.3 %) were excluded. The remaining 90 patients (median age at first visit 29 years [range 16 – 68 years]; 46 males) were followed for a median of 5.1 years (interquartile range [IQR] 3.3 – 7.3 years). During this period, a total of 55 701 polyps were resected without adverse events such as bleeding or perforation. The median numbers of endoscopic treatment sessions and polyps removed per patient were 8 (IQR 6 – 11) and 475 (IQR 211 – 945), respectively. Five patients had noninvasive carcinoma (Category 4.2 according to the revised Vienna classification), detected within 10 months from the start of the follow-up period. All of these patients were treated endoscopically, without signs of recurrence during a median follow-up of 4.3 years (IQR 2.0 – 7.1 years). No invasive colorectal cancer was recorded during the study period. Two patients (2.2 %) underwent colectomy because the polyposis phenotype had changed to dense polyposis.

Conclusion: Endoscopic management of FAP is feasible and safe in the medium term.

• References

• 1 Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600
• 2 Kinzler KW, Nilbert MC, Vogelstein B et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 251: 1366-1370
• 3 van Duijvendijk P, Slors JFM, Taat CW et al. Functional outcome after colectomy and ileorectal anastomosis compared to proctocolectomy and ileo-pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg 1999; 230: 648-654
• 4 Cordero-Fernández C, Pizarro-Moreno A, Garzón-Benavides M et al. Follow-up after surgical treatment of patients with familial adenomatous polyposis: results in a southern Spanish population. Rev Esp Enferm Dig 2007; 99: 440-445
• 5 Douma KF, Bleiker EM, Aaronson NK et al. Long-term compliance with endoscopic surveillance for familial adenomatous polyposis. Colorectal Dis 2010; 12: 1198-1207
• 6 Ellis CN. Colonic adenomatous polyposis syndromes: clinical management. Clin Colon Rectal Surg 2008; 21: 256-262
• 7 Burt RW, Leppert MF, Slattery ML et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004; 127: 444-451
• 8 Hurlstone DP, Cross SS, Slater R et al. Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Gut 2004; 53: 376-380
• 9 Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
• 10 Van Duijvendijk P, Slors JF, Taat CW et al. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2000; 87: 590-596
• 11 Iwama T, Tamura K, Morita T et al. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004; 9: 308-316
• 12 Saurin JC, Napoleon B, Gay G et al. Endoscopic management of patients with familial adenomatous polyposis (FAP) following a colectomy. Endoscopy 2005; 37: 499-501